Beforea | Afterb | New usersc | Former usersd | Net changee (±) | |
---|---|---|---|---|---|
Aspirin | 55.1% | 53.9% | 11.9% | 13.0% | − 1.1% |
Statins | 66.6% | 70.0% | 9.4% | 6.0% | + 3.4% |
Adenosine diphosphate-inhibitors | 3.3% | 4.6% | 2.5% | 1.2% | + 1.3% |
Vitamin-K antagonist | 13.0% | 19.3% | 7.5% | 1.2% | + 6.3% |
Direct oral anti-coagulants | 2.3% | 3.7% | 1.7% | 0.4% | + 1.3% |
Beta-blockers | 46.5% | 52.6% | 13.0% | 6.9% | + 6.1% |
Angiotensin converting enzyme-inhibitors | 41.6% | 43.5% | 7.8% | 5.9% | + 1.9% |
Angiotensin-II receptor blockers | 28.4% | 29.2% | 4.2% | 3.4% | + 0.8% |
Thiazide | 19.4% | 18.1% | 4.5% | 5.8% | − 1.3% |
Calcium-blockers | 32.0% | 33.4% | 7.7% | 6.3% | + 1.4% |
Insulin | 27.0% | 29.9% | 3.8% | 0.9% | + 2.9% |
Non-insulin diabetes medication | 61.6% | 62.2% | 4.6% | 4.0% | + 0.6% |